Lesson from Lilly’s Zyprexa Settlement: Be Proactive In Monitoring Sales Reps
Executive Summary
Companies might shield themselves from claims of off-label drug marketing by adopting oversight procedures mandated in Lilly's corporate integrity agreement with HHS